PRN: U.S. Glucose Testing Markets 2016 - Change is Driven by New Analytical Technologies and Developments in Diabetes Treatment

U.S. Glucose Testing Markets 2016 - Change is Driven by New Analytical Technologies and Developments in Diabetes Treatment [14-January-2016] DUBLIN, Jan. 14, 2016 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/xxnj8m/u_s_glucose) has announced the addition of the "U.S. Glucose Testing Markets" report to their offering.

Persone Laura Wood, Diagnostic
Luoghi Dublino, Stati Uniti d'America
Organizzazioni Prodigy Diabetes Care DiaSys Echo Therapeutics Entra Health Systems, Profiles Companies Mentioned Abaxis Inc. Abbott Laboratories ACON Laboratories AgaMatrix, Each, New Analytical Technologies
Argomenti commercio, impresa, economia

14/gen/2016 09.10.53 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

U.S. Glucose Testing Markets 2016 - Change is Driven by New Analytical Technologies and Developments in Diabetes Treatment

 
[14-January-2016]
 

DUBLIN, Jan. 14, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/xxnj8m/u_s_glucose) has announced the addition of the "U.S. Glucose Testing Markets" report to their offering.

U.S. glucose testing is undergoing a significant transition, driven by new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, several segments of the market, such as home testing devices for diabetes management and point of care (POC) instruments for use in professional settings, will exhibit strong growth. Direct access testing has emerged as a strong force in the blood glucose testing segment, and non-invasive and minimally-invasive testing now represent major new areas for the application of IVD testing.

This report describes the specific market segments for blood glucose testing and diabetes management in the U.S. market. It reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum, plasma or whole-blood glucose concentrations. Additionally, this study examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations.

Moreover, it analyzes almost all of the companies known to be marketing, manufacturing or developing glucose testing products for the U.S. market. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position.

Key Topics Covered:

1. Overview

2. Diabetes

3. Market Analysis: Size, Growth, Share and Competitors

4. Glucose Diagnostic and Monitoring Recommendations

5. Glucose Testing Technology Platforms and Consumable Products

6. Glucose Testing Devices on the Market

7. Business Trends in Glucose Testing

8. Technology Trends

9. Company Profiles

Companies Mentioned

  • Abaxis, Inc.
  • Abbott Laboratories
  • ACON Laboratories
  • AgaMatrix
  • Alere
  • Allmedicus
  • Amedica Biotech
  • A. Menarini Diagnostics
  • Apex Biotechnology Corporation
  • Arkray
  • Bayer
  • B. Braun Melsungen
  • Beckman Coulter
  • Bionime
  • Bio-Rad Laboratories, Inc.
  • BioTex
  • Calisto Medical
  • Cambridge Sensors
  • DexCom
  • Diagnostic Devices/Prodigy Diabetes Care
  • DiaSys
  • Echo Therapeutics
  • Entra Health Systems
  • Fora Care
  • Freedom Meditech
  • Genesis Health Technologies
  • GenExel-Sein
  • GlucoPlus
  • GluMetrics
  • GlySens
  • GlySure Limited
  • Grove Instruments

For more information visit http://www.researchandmarkets.com/research/xxnj8m/u_s_glucose

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl